Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Jifang Sheng and Qin Ning.
Connection Strength

0.150
  1. Efficacy and Safety of All-oral, 12-week Ravidasvir Plus Ritonavir-boosted Danoprevir and Ribavirin in Treatment-naïve Noncirrhotic HCV Genotype 1 Patients: Results from a Phase 2/3 Clinical Trial in China. J Clin Transl Hepatol. 2019 Sep 28; 7(3):213-220.
    View in: PubMed
    Score: 0.053
  2. Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China. BMC Gastroenterol. 2019 May 02; 19(1):65.
    View in: PubMed
    Score: 0.051
  3. Association of baseline vitamin D level with genetic determinants and virologic response in patients with chronic hepatitis B. Hepatol Res. 2018 Feb; 48(3):E213-E221.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.